Home / Biotechnology / Coronary Stents Market - Global Trends, Estimates and Forecasts, 2012-2018

Coronary Stents Market - Global Trends, Estimates and Forecasts, 2012-2018

Published: Nov 2014 | No Of Pages: 615 | Published By: Axis Research Mind
Global Market Watch:
 
Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 40% by 2015 leaving the rest of the market to the bare metal stents and other devices. By Coating, Polymer stent coating segment is the fastest growing market with a CAGR of 8.7% for analysis period 2012-2018.
 
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
 
Report Focus:
 
 
The report ‘Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations. The report primarily focuses on:
  • Emerging Market Trends
  • Advancements in the Technological Space
  • Market Demand of The Segments (By-Region)
  • Key Growth Areas and Market Size
  • Region-Wise Demand Factor
  • Key Competitors Edge
  • Investment Strategies
 
The analysis primarily deals with by type &stent coating. Further, the subdivided categories include:
 
Coronary Stents – By Type & Stent Coating
- By Type
 
a. Drug-Eluting Stents (DES)
b. Bare Metal Stents (BMS)
c. Absorbable Stents/Biodegradable Metallic Stent
d. Anti-Restenosis Devices
i. Bioactive Stent
ii. Radioactive Stent
iii. Drug-Eluting Balloon
By Stent Coating
a. Inorganic (PERSE, Gold, Silicon Carbide, Iridium Oxide, Carbon, Titanium-Nitride-Oxide)
b. Polymer (Biodegradable & Non-Biodegradable)
c. Non-Polymer (Microporous, Microstructured, Slotted Tubular, Nanoporous, Nanopatterned)
d. Other Coatings (Heparin, Hyaluronic Acid, Fibrin), Technologies & R&D
 
The period considered for the coronary stentsmarket analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.
 
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 222 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
 
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
I. REPORT FOCUS
A. INTRODUCTION
 
CARDIOLOGY
 
KINDS OF CARDIAC CONDITIONS
A. BLOOD FLOW IN THE HEART
 
B. HEART MALFUNCTION
TYPES OF CARDIAC ARREST
 
C. MYOCARDIUM
DISORDERS OF MYOCARDIUM
 
D. PERICARDIUM
 
E. HEART VALVES
DISORDERS OF HEART VALVES
 
F. CONGENITAL HEART DEFECT
TYPES OF CONGENITAL HEART DEFECT
 
G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)
 
H. HEART FAILURE
 
B. CARDIOVASCULAR DEVICES
DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
TOOLS DEPLOYED IN CARDIOLOGY
DIAGNOSTIC TESTS AND PROCEDURES
CONCLUSION
 
C. INTERVENTIONAL CARDIOLOGY
 
A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES
I. INTRAVENOUS ULTRASOUND (IVUS)
II. OPTICAL COHERENCE TOMOGRAPHY (OCT)
III. FRACTIONAL FLOW RESERVE (FFR) - A BIG TECHNOLOGICAL BREAKTHROUGH
IMPLICATIONS OF FFR GROWTH - FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES
FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM
EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR
THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR
PERCUTANEOUS CORONARY INTERVENTION (PCI)
 
B. INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
 
ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS
STENT SCAFFOLD STRUCTURE
 
CORONARY STENT COATING TYPES - IN BRIEF
TYPES OF STENT COATINGS, IN BRIEF:-
 
A. INORGANIC COATINGS
GOLD
SILICON CARBIDE
IRIDIUM OXIDE
CARBON
TITANIUM-NITRIDE-OXIDE
 
B. POLYMER COATINGS
NON-BIODEGRADABLE POLYMERS
BIODEGRADABLE POLYMERS
 
C. NON-POLYMER COATINGS/SURFACES:
MICROPOROUS SURFACES
MICROSTRUCTURED SURFACES
SLOTTED TUBULAR SURFACES
NANOPOROUS SURFACES
NPS
NANO-PATTERNED SURFACES
 
D. OTHER COATINGS/STRATEGIES
HEPARIN
HYALURONIC ACID (HA)
FIBRIN
ENDOTHELIAL CELLS (EC)
CONCLUSION
 
CARDIAC STENT USAGE IN THE US
PROCEDURES PERFORMED
PREFERRED STENT TYPE
STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS
 
A. DRUG-ELUTING STENTS (DES)
DIAGNOSTICS LIKELY TO CHANGE DES USAGE
INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE
DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS
DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION
ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE
THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY
GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES’ IN THE LATE 90’S
US AND JAPAN BREAKDOWN OF PCI CASES
GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE
NEXT GENERATION STENTS - BVS, SYNERGY, TCD-10023 AND BIOFREEDOM
FIRST-GENERATION STENTS
SECOND-GENERATION STENTS
THIRD-GENERATION STENTS
 
B. BARE METAL STENTS (BMS)
BARE-METAL AND DRUG-ELUTING STENTS MARKET
 
C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT
BIOABSORBABLE STENT SCAFFOLDS
SELF-EXPANDING STENT SCAFFOLDS
MICROMESH COVERED STENT
DEDICATED BIFURCATION STENTS
SPECULATION ON BIO-ABSORBABLE STENTS
 
D. ANTI-RESTENOSIS DEVICES
VASCULAST™ - DRUG ELUTING COATING
COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY
DRUG ELUTING BALLOONS
CONCLUSION
 
NEW DIRECTIONS FOR STENT TECHNOLOGY
STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES
BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS
BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH
 
D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
II. MARKET ANALYSIS
CORONARY STENTS – INDUSTRY SNAPSHOT
 
A. CORONARY STENTS - SEGMENTATION
CORONARY STENTS - GLOBAL
CORONARY STENTS - BY GEOGRAPHY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
CORONARY STENTS – BY TYPE
CORONARY STENTS - TYPE - BY GEOGRAPHY
DRUG-ELUTING STENTS (DES)
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
BARE METAL STENTS (BMS)
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
ABSORBABLE STENTS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
ANTI-RESTENOSIS DEVICES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
CORONARY STENTS – BY STENT COATING
CORONARY STENTS - STENT COATING - BY GEOGRAPHY
INORGANIC
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
POLYMER
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
NON-POLYMER
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
OTHER STENT COATINGS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
 
B. GROWTH RATE ANALYSIS
GLOBAL CORONARY STENTS - MARKET GROWTH RATES
GLOBAL CORONARY STENTS - TYPE - GROWTH RATES
GLOBAL CORONARY STENTS - STENT COATING - GROWTH RATES
 
C. INVESTMENT FOCUS
 
III. INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS
 
A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE
 
CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES
 
CARDIAC PACEMAKER DEVICES
THE DATA COLLECTION WORK
 
CARDIAC RESYNCHRONIZATION THERAPY (CRT)
 
CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
 
INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
 
FFR IMPACT ON DES MARKET
MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET
 
CARDIAC CATHETERS
COMPETITIVE ANALYSIS
 
ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
 
EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL
 
ATRIAL FIBRILLATION (AF)
 
INTRAVASCULAR ULTRASOUND (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
 
PERIPHERAL VASCULAR DEVICES
ARTERIOTOMY CLOSURE DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION
 
PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES
 
PROSTHETIC HEART VALVES
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES
 
B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES
 
C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY
 
ECONOMIC COST OF CARDIOVASCULAR DISEASES
 
COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
 
CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
 
D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
 
E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES
 
F. MARKET TRENDS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL 
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
GE HEALTHCARE’S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE’S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK’S NEW EVIA HF-T PACEMAKER.
AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN. 
MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
DRUG-ELUTING STENTS ARE SECURE
CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
STUDY REVEALS THAT BAYER HEALTHCARE’S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)  
EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
ZOLL NOMINATED TO GLOBE 100 AGAIN
USCOM ENTERS EUROPEAN MARKETS
POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
USCOM SECURES STRONG PRESENCE IN US AND CANADA
CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
STENTYS’S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT 
CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
USCOM EYES EASTERN EUROPEAN MARKET
VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
INFECTIONS FROM IMPLANTED CARDIAC DEVICES
TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
HEART TRANSPLANTS SUBSTITUTED BY A PUMP
DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
REMOTE MONITORING OF HEART FAILURE PATIENTS
EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
OVER-THE-COUNTER APPARATUS
BOSTON SCIENTIFICS’ IMPLANTABLE DEFIBRILLATOR
CARDIAC SCIENCE’S NEW CARDIAC TREATMENT
THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
LOCAL MEDICARE’S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
BEST AND LATEST SELF-TEACHING HEART SOUNDS
REPLACING VALVE WITHOUT CARDIAC SUPPORT
U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS
 
G. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD
 
OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES
 
CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
 
CARDIAC MEDICAL DEVICES – PATENTS
 
KEY COMPANIES FINANCIAL OVERVIEW
 
IV. INDUSTRY COMPANY DATABASE
 
V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK
I. REPORT FOCUS
1. COMPARISON PCI GUIDELINE IN US AND EU FOR IVUS/OCT/FFR
2. LIST OF DEDICATED CORONARY BIFURCATION STENTS
3. CURRENTLY AVAILABLE BARE-METAL CORONARY STENT SYSTEMS
4. BIOABSORBABLE SCAFFOLDS (ADVANTAGES AND DISADVANTAGES)
5. LIST OF BIOABSORBABLE STENTS WITH CHARACTERISTICS AND CLINICAL EVIDENCE
6. CONTEMPORARY DRUG ELUTING BALLOONS
 
D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING
NORTH AMERICA
7. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR NORTH AMERICA - (2012-2018, IN USD$ MILLION)
8. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF NORTH AMERICA MARKET VALUE - (2015 - 2018)
9. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR NORTH AMERICA - (2012-2018, IN USD$ MILLION)
10. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF NORTH AMERICA MARKET VALUE - (2015 - 2018)
 
EUROPE
11. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR EUROPE - (2012-2018, IN USD$ MILLION)
12. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF EUROPEAN MARKET VALUE - (2015 - 2018)
13. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR EUROPE - (2012-2018, IN USD$ MILLION)
14. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF EUROPEAN MARKET VALUE - (2015 - 2018)
 
ASIA-PACIFIC
15. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
16. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF ASIA-PACIFIC MARKET VALUE - (2015 - 2018)
17. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
18. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF ASIA-PACIFIC MARKET VALUE - (2015 - 2018)
 
LATIN AMERICA
19. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR LATIN AMERICA - (2012-2018, IN USD$ MILLION)
20. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF LATIN AMERICA MARKET VALUE - (2015 - 2018)
21. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR LATIN AMERICA - (2012-2018, IN USD$ MILLION)
22. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF LATIN AMERICA MARKET VALUE - (2015 - 2018)
 
REST OF WORLD
23. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR REST OF WORLD - (2012-2018, IN USD$ MILLION)
24. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF REST OF WORLD MARKET VALUE - (2015 - 2018)
25. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR REST OF WORLD - (2012-2018, IN USD$ MILLION)
26. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF REST OF WORLD MARKET VALUE - (2015 - 2018)
 
27. CORONARY STENTS - PRODUCT BY BRANDS
 
II. MARKET ANALYSIS
28. GLOBAL CORONARY STENTS - SEGMENTATION BY TYPE
 
CORONARY STENTS - GLOBAL
29. CORONARY STENTS MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
30. CORONARY STENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
31. CORONARY STENTS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
CORONARY STENTS - BY GEOGRAPHY
NORTH AMERICA
32. CORONARY STENTS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
33. CORONARY STENTS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
34. CORONARY STENTS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
35. CORONARY STENTS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
36. CORONARY STENTS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
37. CORONARY STENTS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
38. CORONARY STENTS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
39. CORONARY STENTS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
40. CORONARY STENTS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
41. CORONARY STENTS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
CORONARY STENTS – BY TYPE
42. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
43. CORONARY STENTS - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF GLOBAL MARKET VALUE - (2015-2018)
 
CORONARY STENTS - TYPE - BY GEOGRAPHY
DRUG-ELUTING STENTS (DES)
44. DRUG-ELUTING STENTS (DES) MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
45. DRUG-ELUTING STENTS (DES) - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
46. DRUG-ELUTING STENTS (DES) MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
47. DRUG-ELUTING STENTS (DES) - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
48. DRUG-ELUTING STENTS (DES) MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
49. DRUG-ELUTING STENTS (DES) - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
50. DRUG-ELUTING STENTS (DES) MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
51. DRUG-ELUTING STENTS (DES) - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
52. DRUG-ELUTING STENTS (DES) MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
53. DRUG-ELUTING STENTS (DES) - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
54. DRUG-ELUTING STENTS (DES) MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
55. DRUG-ELUTING STENTS (DES) - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
BARE METAL STENTS (BMS)
56. BARE METAL STENTS (BMS) MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
57. BARE METAL STENTS (BMS) - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
58. BARE METAL STENTS (BMS) MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
59. BARE METAL STENTS (BMS) - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
60. BARE METAL STENTS (BMS) MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
61. BARE METAL STENTS (BMS) - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
62. BARE METAL STENTS (BMS) MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
63. BARE METAL STENTS (BMS) - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
64. BARE METAL STENTS (BMS) MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
65. BARE METAL STENTS (BMS) - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
66. BARE METAL STENTS (BMS) MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
67. BARE METAL STENTS (BMS) - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
ABSORBABLE STENTS
68. ABSORBABLE STENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
69. ABSORBABLE STENTS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
70. ABSORBABLE STENTS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
71. ABSORBABLE STENTS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
72. ABSORBABLE STENTS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
73. ABSORBABLE STENTS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
74. ABSORBABLE STENTS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
75. ABSORBABLE STENTS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
76. ABSORBABLE STENTS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
77. ABSORBABLE STENTS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
78. ABSORBABLE STENTS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
79. ABSORBABLE STENTS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
ANTI-RESTENOSIS DEVICES
80. ANTI-RESTENOSIS DEVICES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
81. ANTI-RESTENOSIS DEVICES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
82. ANTI-RESTENOSIS DEVICES MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
83. ANTI-RESTENOSIS DEVICES - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
84. ANTI-RESTENOSIS DEVICES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
85. ANTI-RESTENOSIS DEVICES - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
86. ANTI-RESTENOSIS DEVICES MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
87. ANTI-RESTENOSIS DEVICES - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
88. ANTI-RESTENOSIS DEVICES MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
89. ANTI-RESTENOSIS DEVICES - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
90. ANTI-RESTENOSIS DEVICES MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
91. ANTI-RESTENOSIS DEVICES - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
CORONARY STENTS – BY STENT COATING
92. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
93. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF GLOBAL MARKET VALUE - (2015-2018)
 
CORONARY STENTS - STENT COATING - BY GEOGRAPHY
INORGANIC
94. INORGANIC MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
95. INORGANIC - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
96. INORGANIC MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
97. INORGANIC - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
98. INORGANIC MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
99. INORGANIC - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
100. INORGANIC MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
101. INORGANIC - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
102. INORGANIC MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
103. INORGANIC - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
104. INORGANIC MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
105. INORGANIC - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
POLYMER
106. POLYMER MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
107. POLYMER - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
108. POLYMER MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
109. POLYMER - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
110. POLYMER MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
111. POLYMER - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
112. POLYMER MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
113. POLYMER - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
114. POLYMER MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
115. POLYMER - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
116. POLYMER MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
117. POLYMER - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
NON-POLYMER
118. NON-POLYMER MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
119. NON-POLYMER - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
120. NON-POLYMER MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
121. NON-POLYMER - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
122. NON-POLYMER MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
123. NON-POLYMER - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
124. NON-POLYMER MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
125. NON-POLYMER - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
126. NON-POLYMER MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
127. NON-POLYMER - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
128. NON-POLYMER MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
129. NON-POLYMER - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
OTHER STENT COATINGS
130. OTHER STENT COATINGS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
131. OTHER STENT COATINGS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
 
NORTH AMERICA
132. OTHER STENT COATINGS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
133. OTHER STENT COATINGS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
 
EUROPE
134. OTHER STENT COATINGS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
135. OTHER STENT COATINGS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
 
ASIA-PACIFIC
136. OTHER STENT COATINGS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
137. OTHER STENT COATINGS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
 
LATIN AMERICA
138. OTHER STENT COATINGS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
139. OTHER STENT COATINGS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
 
REST OF WORLD
140. OTHER STENT COATINGS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
141. OTHER STENT COATINGS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
 
B. GROWTH RATE ANALYSIS
GLOBAL CORONARY STENTS - MARKET GROWTH RATES
142. CORONARY STENTS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2012-2018)
 
GLOBAL CORONARY STENTS - TYPE - GROWTH RATES
143. CORONARY STENTS - TYPES - % GROWTH RATE FORECASTS FOR DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - (2012-2018)
 
GLOBAL CORONARY STENTS - STENT COATING - GROWTH RATES
144. CORONARY STENTS - STENT COATING - % GROWTH RATE FORECASTS FOR INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - (2012-2018)
 
C. INVESTMENT FOCUS
145. CORONARY STENTS - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
146. CORONARY STENTS - TYPES - DRUG ELUTING STENTS, BARE METAL STENTS, ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
147. CORONARY STENTS - COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER & R&D - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
 
III. INDUSTRY OVERVIEW
148: INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
149: INTRAVENOUS DIAGNOSTICS – BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
150. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
151. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
152. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
153. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
154. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
155. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
156. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
157. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
158. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
159. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
160. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
161. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
162. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
163. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
164. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
165. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
166. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
167. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
168. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)
169. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
170. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
171. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
172. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
173. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
174. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
175. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
176. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
177. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
178. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
179. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
180. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
181. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
182. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
183. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
184. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
185. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
186. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
187. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
188. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
189. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
190. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
191. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
192. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
193. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
194. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
195. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
196. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
197. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
198. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
199. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
200. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
201. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
202. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
203. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
204. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
205. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
206. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
207. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
208. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
209. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
210. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
211. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
212. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
213. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
214. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
215. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
216. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
217. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
218. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
219. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
220. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
221. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
222. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘Y’ YEN)
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +